Alessandra Mosca
0000-0003-2538-8411
Publication & Citation Trends
Publications
155 total
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group? PDF
Cited by 64
OpenAlex
Transplantation de microbiote fécale hors infections à C. difficile. Expérience Française de 2019 à 2022.
Cited by 0
Semantic Scholar
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study PDF
Cited by 165
OpenAlex
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features
Cited by 61
OpenAlex
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis PDF
Cited by 105
OpenAlex
Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma
Cited by 60
OpenAlex
Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort
Cited by 63
OpenAlex
Attribut et prédicat dans les grammaires françaises et italiennes OA
Cited by 1
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(50)
Renal cell carcinoma treatment
(39)
Cancer Genomics and Diagnostics
(24)
Renal and related cancers
(18)
Prostate Cancer Diagnosis and Treatment
(17)
Affiliations
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
Consejo Nacional de Investigaciones Científicas y Técnicas
Délégation Paris 7
Ipsen (France)
Université Paris Cité